Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shixia Huang

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
A cross-sectional analysis of the vaginal microenvironment in rheumatoid arthritisMarlyd E Mejia, Savannah Bowman, Jessica Lee, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Rat somatic genome editing enables ER+ breast cancer modelingWen Bu, Tobie Lee, Meenakshi Anurag, et al.
Elife|April 10, 2026
Loss of ZNRF3/RNF43 unleashes EGFR in cancerFei Yue, Amy T Ku, Payton D Stevens, et al.
Elife|January 2, 2014
Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancySvasti Haricharan, Jie Dong, Sarah Hein, et al.
Endocrine-Related Cancer|October 12, 2021
Inhibition of GATA2 in prostate cancer by a clinically available small moleculeSalma Kaochar, Aleksandra Rusin, Christopher Foley, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Loss of ZNRF3/RNF43 Unleashes EGFR in CancerFei Yue, Amy T Ku, Payton D Stevens, et al.
Scientific Reports|September 14, 2017
A new mild hyperthermia device to treat vascular involvement in cancer surgeryMatthew J Ware, Lam P Nguyen, Justin J Law, et al.
Cancer Discovery|August 13, 2017
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast CancerSvasti Haricharan, Nindo Punturi, Purba Singh, et al.
The Journal of Clinical Investigation|February 3, 2022
Targeting TGF-β for treatment of osteogenesis imperfectaI-Wen Song, Sandesh Cs Nagamani, Dianne Nguyen, et al.
Oncogene|October 19, 2022
STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potentialMeng Lin, Amy T Ku, Jie Dong, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
A cross-sectional analysis of the vaginal microenvironment in rheumatoid arthritisMarlyd E Mejia, Savannah Bowman, Jessica Lee, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Rat somatic genome editing enables ER+ breast cancer modelingWen Bu, Tobie Lee, Meenakshi Anurag, et al.
Elife|April 10, 2026
Loss of ZNRF3/RNF43 unleashes EGFR in cancerFei Yue, Amy T Ku, Payton D Stevens, et al.
Elife|January 2, 2014
Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancySvasti Haricharan, Jie Dong, Sarah Hein, et al.
Endocrine-Related Cancer|October 12, 2021
Inhibition of GATA2 in prostate cancer by a clinically available small moleculeSalma Kaochar, Aleksandra Rusin, Christopher Foley, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Loss of ZNRF3/RNF43 Unleashes EGFR in CancerFei Yue, Amy T Ku, Payton D Stevens, et al.
Scientific Reports|September 14, 2017
A new mild hyperthermia device to treat vascular involvement in cancer surgeryMatthew J Ware, Lam P Nguyen, Justin J Law, et al.
Cancer Discovery|August 13, 2017
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast CancerSvasti Haricharan, Nindo Punturi, Purba Singh, et al.
The Journal of Clinical Investigation|February 3, 2022
Targeting TGF-β for treatment of osteogenesis imperfectaI-Wen Song, Sandesh Cs Nagamani, Dianne Nguyen, et al.
Oncogene|October 19, 2022
STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potentialMeng Lin, Amy T Ku, Jie Dong, et al.
Pageof 10